Cryo-Cell International, Inc. CCEL
AMEX
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 7.82M | 7.78M | 7.68M | 7.84M | 7.83M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.82M | 7.78M | 7.68M | 7.84M | 7.83M |
| Cost of Revenue | 1.61M | 1.68M | 1.66M | 6.09M | 1.80M |
| Gross Profit | 6.21M | 6.10M | 6.03M | 1.75M | 6.02M |
| SG&A Expenses | 3.78M | 4.62M | 5.01M | 5.45M | 3.88M |
| Depreciation & Amortization | 184.50K | 184.30K | 183.90K | 183.80K | 185.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.63M | 6.58M | 6.92M | 11.81M | 5.92M |
| Operating Income | 2.19M | 1.20M | 765.10K | -3.97M | 1.90M |
| Income Before Tax | 1.83M | 827.80K | 70.30K | -4.63M | 1.19M |
| Income Tax Expenses | 555.00K | 273.20K | 23.20K | -814.50K | 436.60K |
| Earnings from Continuing Operations | 1.27M | 554.60K | 47.10K | -3.82M | 749.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.27M | 554.60K | 47.10K | -3.82M | 749.40K |
| EBIT | 2.19M | 1.20M | 765.10K | -3.97M | 1.90M |
| EBITDA | 2.43M | 1.44M | 1.01M | -3.72M | 2.14M |
| EPS Basic | 0.16 | 0.07 | 0.01 | -0.47 | 0.09 |
| Normalized Basic EPS | 0.14 | 0.06 | 0.02 | -0.34 | 0.11 |
| EPS Diluted | 0.16 | 0.07 | 0.01 | -0.47 | 0.09 |
| Normalized Diluted EPS | 0.14 | 0.06 | 0.02 | -0.34 | 0.11 |
| Average Basic Shares Outstanding | 8.06M | 8.06M | 8.06M | 8.06M | 8.06M |
| Average Diluted Shares Outstanding | 8.07M | 8.06M | 8.06M | 8.06M | 8.07M |
| Dividend Per Share | -- | -- | -- | 0.00 | 0.00 |
| Payout Ratio | -- | -- | -- | 0.00% | 0.00% |